Literature DB >> 8083999

trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.

M Ushikai1, M J Lace, Y Yamakawa, M Kono, J Anson, T Ishiji, S Parkkinen, N Wicker, M E Valentine, I Davidson.   

Abstract

Papillomaviral E2 genes encode proteins that regulate viral transcription. While the full-length bovine papillomavirus type 1 (BPV-1) E2 peptide is a strong trans activator, the homologous full-length E2 product of human papillomavirus type 16 (HPV-16) appeared to vary in function in previous studies. Here we show that when expressed from comparable constructs, the full-length E2 products of HPV-16 and BPV-1 trans activate a simple E2- and Sp1-dependent promoter up to approximately 100-fold in human keratinocytes and other epithelial cells as well as human and animal fibroblasts. Vaccinia virus-expressed, purified full-length HPV-16 and BPV-1 E2 proteins bound a consensus E2 site with high specific affinities (Kd = approximately 10(-9) M) and stimulated in vitro transcription up to six- to eightfold. In vivo and in vitro trans activation by either E2 protein required cooperation with another activator, such as Sp1, or other factors that interact with papillomavirus promoters, such as AP-1, Oct-1, nuclear factor 1/CTF, transcriptional enhancer factor 1, or USF. The glutamine-rich domain B of Sp1 or the mutually unrelated activation domains of other transcription factors were necessary and sufficient for cooperation with either E2 factor. We conclude that like BPV-1 E2, the HPV-16 E2 protein has the potential to function as a strong activator of viral gene expression in cooperation with cellular transcription factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083999      PMCID: PMC237086     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Functional analysis of E2-mediated repression of the HPV18 P105 promoter.

Authors:  F Thierry; P M Howley
Journal:  New Biol       Date:  1991-01

2.  The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.

Authors:  N Dostatni; P F Lambert; R Sousa; J Ham; P M Howley; M Yaniv
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

3.  Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.

Authors:  P Monini; S R Grossman; B Pepinsky; E J Androphy; L A Laimins
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.

Authors:  R Li; J D Knight; S P Jackson; R Tjian; M R Botchan
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

5.  Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1.

Authors:  J H Xiao; I Davidson; H Matthes; J M Garnier; P Chambon
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

Review 6.  Transforming activity of bovine and human papillomaviruses in cultured cells.

Authors:  D DiMaio
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

7.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.

Authors:  E Pascal; R Tjian
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

8.  Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.

Authors:  T P Cripe; A Alderborn; R D Anderson; S Parkkinen; P Bergman; T H Haugen; U Pettersson; L P Turek
Journal:  New Biol       Date:  1990-05

9.  Enhancer activation by a single type of transcription factor shows cell type dependence.

Authors:  M Forsberg; G Westin
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

10.  Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames.

Authors:  M Ustav; A Stenlund
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more
  24 in total

1.  Relationship between retroviral DNA integration and gene expression.

Authors:  J B Weidhaas; E L Angelichio; S Fenner; J M Coffin
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication.

Authors:  M K Ferguson; M R Botchan
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants.

Authors:  A Abroi; R Kurg; M Ustav
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain.

Authors:  D E Breiding; F Sverdrup; M J Grossel; N Moscufo; W Boonchai; E J Androphy
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

8.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

9.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

10.  Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.

Authors:  C D Newhouse; S J Silverstein
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.